CatalystIQDrug pipeline intelligence

Know a catalyst is coming
before the market reprices it.

CatalystIQ reads ClinicalTrials.gov, the FDA and the Orange Book directly, diffs every sweep, and turns the result into a catalyst calendar with the patent cliffs behind it. It is in open beta: the whole calendar is readable without an account. It is an information tool, not investment advice.

Open the dashboard See pricing
Upcoming catalysts
57
Patent cliffs (12mo)
2312
Recent FDA approvals
13
Tracked trials
—
Pharma headlines
60
Nearest catalysts Live
CompanyCatalystDate
GEN NewsNews catalyst2026-10-07
BioPharma DiveNews catalyst2026-10-07
GEN NewsNews catalyst2026-10-06
BioPharma DiveNews catalyst2026-10-06
BioPharma DiveNews catalyst2026-10-05
FDA Press ReleasesNews catalyst2026-10-01
FDA Press ReleasesNews catalyst2026-09-28
FDA Press ReleasesNews catalyst2026-09-17
FDA Press ReleasesNews catalyst2026-09-04
FDA Press ReleasesNews catalyst2026-09-03
FDA Press ReleasesNews catalyst2026-09-03
FDA Press ReleasesNews catalyst2026-08-28
FDA Press ReleasesNews catalyst2026-08-27
FDA Press ReleasesNews catalyst2026-08-27
FDA Press ReleasesNews catalyst2026-08-26
MERCK SHARP AND DOHME CORPJUVISYNC · Patent expiry2026-10-11
MERCK SHARP AND DOHME CORPJUVISYNC · Patent expiry2026-10-11
MERCK SHARP AND DOHME CORPJUVISYNC · Patent expiry2026-10-11
MERCK SHARP AND DOHME CORPJUVISYNC · Patent expiry2026-10-11
MERCK SHARP AND DOHME CORPJUVISYNC · Patent expiry2026-10-11
MERCK SHARP AND DOHME CORPJUVISYNC · Patent expiry2026-10-11
BESINS HEALTHCARE IRELAND LTDANDROGEL · Patent expiry2026-10-12
BESINS HEALTHCARE IRELAND LTDANDROGEL · Patent expiry2026-10-12
BESINS HEALTHCARE IRELAND LTDANDROGEL · Patent expiry2026-10-12
BESINS HEALTHCARE IRELAND LTDANDROGEL · Patent expiry2026-10-12
BESINS HEALTHCARE IRELAND LTDANDROGEL · Patent expiry2026-10-12
BESINS HEALTHCARE IRELAND LTDANDROGEL · Patent expiry2026-10-12
MEDEXUS PHARMA INCGRAFAPEX · Patent expiry2026-10-12
MEDEXUS PHARMA INCGRAFAPEX · Patent expiry2026-10-12
BESINS HEALTHCARE IRELAND LTDANDROGEL · Patent expiry2026-10-12
BESINS HEALTHCARE IRELAND LTDANDROGEL · Patent expiry2026-10-12
BESINS HEALTHCARE IRELAND LTDANDROGEL · Patent expiry2026-10-12
BESINS HEALTHCARE IRELAND LTDANDROGEL · Patent expiry2026-10-12
BESINS HEALTHCARE IRELAND LTDANDROGEL · Patent expiry2026-10-12
BESINS HEALTHCARE IRELAND LTDANDROGEL · Patent expiry2026-10-12
BESINS HEALTHCARE IRELAND LTDANDROGEL · Patent expiry2026-10-12
BESINS HEALTHCARE IRELAND LTDANDROGEL · Patent expiry2026-10-12
BESINS HEALTHCARE IRELAND LTDANDROGEL · Patent expiry2026-10-12
BESINS HEALTHCARE IRELAND LTDANDROGEL · Patent expiry2026-10-12
BESINS HEALTHCARE IRELAND LTDANDROGEL · Patent expiry2026-10-12
Open the dashboard

Showing the 40 nearest of 57 upcoming catalysts. The dashboard adds trial status transitions, FDA filings, patent cliffs, IP movements and the research feed. An account adds alerts and a watchlist — create a free one.

A / Primary sources

ClinicalTrials.gov, openFDA, the FDA Orange Book, SEC EDGAR, Europe PMC and Yahoo Finance, read directly rather than re-summarised by a third party.

B / Change detection

Each sweep is diffed against the previous one, so a trial moving from recruiting to active — or a new PDUFA date — surfaces as an event rather than a row you would have to notice yourself.

C / Patent cliffs

Real expiration data from the Orange Book, so the competitive picture is visible years out rather than guessed at from filings.